HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simpson, J M
Right arrow Articles by Sharland, G K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simpson, J M
Right arrow Articles by Sharland, G K

Heart 1998;79:576-581 ( June )

Fetal tachycardias: management and outcome of 127 consecutive cases

J M Simpson, G K Sharland

Department of Fetal Cardiology, 15th Floor, Guy's Hospital, London SE1 9RT, UK

Correspondence to: Dr Simpson.

Accepted for publication 3 February 1998

Objective---To review the management and outcome of fetal tachycardia, and to determine the problems encountered with various treatment protocols.
Study design---Retrospective analysis.
Subjects---127 consecutive fetuses with a tachycardia presenting between 1980 and 1996 to a single tertiary centre for fetal cardiology. The median gestational age at presentation was 32 weeks (range 18 to 42).
Results---105 fetuses had a supraventricular tachycardia and 22 had atrial flutter. Overall, 52 fetuses were hydropic and 75 non-hydropic. Prenatal control of the tachycardia was achieved in 83% of treated non-hydropic fetuses compared with 66% of the treated hydropic fetuses. Digoxin monotherapy converted most (62%) of the treated non-hydropic fetuses, and 96% survived through the neonatal period. First line drug treatment for hydropic fetuses was more diverse, including digoxin (n = 5), digoxin plus verapamil (n = 14), and flecainide (n = 27). The response rates to these drugs were 20%, 57%, and 59%, respectively, confirming that digoxin monotherapy is a poor choice for the hydropic fetus. Response to flecainide was faster than to the other drugs. Direct fetal treatment was used in four fetuses, of whom two survived. Overall, 73% (n = 38) of the hydropic fetuses survived. Postnatally, 4% of the non-hydropic group had ECG evidence of pre-excitation, compared with 16% of the hydropic group; 57% of non-hydropic fetuses were treated with long term antiarrhythmics compared with 79% of hydropic fetuses.
Conclusions---Non-hydropic fetuses with tachycardias have a very good prognosis with transplacental treatment. Most arrhythmias associated with fetal hydrops can be controlled with transplacental treatment, but the mortality in this group is 27%. At present, there is no ideal treatment protocol for these fetuses and a large prospective multicentre trial is required to optimise treatment of both hydropic and non-hydropic fetuses.

Keywords: fetal tachycardia;  atrial flutter;  supraventricular tachycardia

© 1998 by Heart


This article has been cited by other articles:


Home page
 CirculationHome page
N. D. Hahurij, A. C. Gittenberger-De Groot, D. P. Kolditz, R. Bokenkamp, M. J. Schalij, R. E. Poelmann, and N. A. Blom
Accessory Atrioventricular Myocardial Connections in the Developing Human Heart: Relevance for Perinatal Supraventricular Tachycardias
Circulation, June 3, 2008; 117(22): 2850 - 2858.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
S. A.S. Killen and F. A. Fish
Fetal and Neonatal Arrhythmias
NeoReviews, June 1, 2008; 9(6): e242 - e252.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
L. K Hornberger and D. J Sahn
Rhythm abnormalities of the fetus
Heart, October 1, 2007; 93(10): 1294 - 1300.
[Full Text] [PDF]

Home page
 Obstet GynecolHome page
J. Q. Campbell, T. H. Best, H. Eswaran, and C. L. Lowery
Fetal and Maternal Magnetocardiography During Flecainide Therapy for Supraventricular Tachycardia.
Obstet. Gynecol., September 1, 2006; 108(3 Pt 2): 767 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. Garland, K. M. Abildskov, S. Taylor, K. Benzeroual, C. S. Caspersen, S. E. Arroyo, T.-w. Kiu, B. Reznik, P. Weldy, S. S. Daniel, et al.
FETAL MORPHINE METABOLISM AND CLEARANCE ARE CONSTANT DURING LATE GESTATION
Drug Metab. Dispos., April 1, 2006; 34(4): 636 - 646.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
H. R. Singh, S. Garekar, M. L. Epstein, and T. L'Ecuyer
Neonatal Supraventricular Tachycardia (SVT)
NeoReviews, July 1, 2005; 6(7): e339 - e350.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. R. Schmidt, S. B. Kristiansen, P. White, M. Smerup, H. E. Botker, M. Vogel, V. Hjortdal, K. Sorensen, and A. Redington
Glucose-insulin infusion improves cardiac function during fetal tachycardia
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 445 - 452.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. F. Strasburger, B. F. Cuneo, M. M. Michon, N. L. Gotteiner, B. J. Deal, S. N. McGregor, M. A. Oudijk, E. J. Meijboom, L. Feinkind, M. Hussey, et al.
Amiodarone Therapy for Drug-Refractory Fetal Tachycardia
Circulation, January 27, 2004; 109(3): 375 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
T. Boldt, M. Eronen, and S. Andersson
Long-Term Outcome in Fetuses With Cardiac Arrhythmias
Obstet. Gynecol., December 1, 2003; 102(6): 1372 - 1379.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Committee Members, C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, et al.
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias --executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society
J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1493 - 1531.
[Full Text] [PDF]

Home page
 CirculationHome page
C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, B. B. Lerman, et al.
ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias*--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)
Circulation, October 14, 2003; 108(15): 1871 - 1909.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Committee Members, C. Blomstrom-Lundqvist, M. M Scheinman, E. M Aliot, J. S Alpert, H. Calkins, A.J. Camm, W.B. Campbell, D. E Haines, K. H Kuck, et al.
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: A Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)Developed in collaboration with NASPE-Heart Rhythm Society
Eur. Heart J., October 2, 2003; 24(20): 1857 - 1897.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
C. M Hall and M. P W. Platt
Neonatal flecainide toxicity following supraventricular tachycardia treatment
Ann. Pharmacother., September 1, 2003; 37(9): 1343 - 1344.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. A. Oudijk, J. M. Ruskamp, F. F. T. Ververs, E. B. Ambachtsheer, P. Stoutenbeek, G. H. A. Visser, and E. J. Meijboom
Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics
J. Am. Coll. Cardiol., August 20, 2003; 42(4): 765 - 770.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
M Krapp, T Kohl, J M Simpson, G K Sharland, A Katalinic, and U Gembruch
Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia
Heart, August 1, 2003; 89(8): 913 - 917.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
L. M. Jones and S. H. Garmel
Successful Digoxin Therapy of Fetal Supraventricular Tachycardia in a Triplet Pregnancy
Obstet. Gynecol., November 1, 2001; 98(5): 921 - 923.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
H.L. Tan and K.I. Lie
Treatment of tachyarrhythmias during pregnancy and lactation
Eur. Heart J., March 2, 2001; 22(6): 458 - 464.
[PDF]

Home page
 Obstet GynecolHome page
B. F. CUNEO and J. F. STRASBURGER
Management Strategy for Fetal Tachycardia
Obstet. Gynecol., October 1, 2000; 96(4): 575 - 581.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. A. Oudijk, M. M. Michon, C. S. Kleinman, L. Kapusta, P. Stoutenbeek, G. H. A. Visser, and E. J. Meijboom
Sotalol in the Treatment of Fetal Dysrhythmias
Circulation, June 13, 2000; 101(23): 2721 - 2726.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Kohl, P. F. Kirchhof, W. Gogarten, J. Reckers, B. Asfour, R. Witteler, W. Haverkamp, L. Eckardt, A. E. Marcus, H. VanAken, et al.
Fetoscopic Transesophageal Electrocardiography and Stimulation in Fetal Sheep : A Minimally Invasive Approach Aimed at Diagnosis and Termination of Therapy-Refractory Supraventricular Tachycardias in Human Fetuses
Circulation, August 17, 1999; 100(7): 772 - 776.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 BMJ Publishing Group Ltd & British Cardiovascular Society